Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Ramon Diaz-Arrastia
Study ID
NCT06963775
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Traumatic Brain Injury

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel) — DEVICE
    Delphi-MD utilizes the use of transcranial magnetic stimulation evoked electroencephalography (TMS-EEG) for diagnostic purposes in a wide range of neurological disorders. Delphi-MD includes a magnetic stimulator and coil, an EEG amplifier and electrode cap and software for the acquisition and analysis of the data. Delphi-MD stimulation protocol includes low intensities (sub motor thresholds) and frequencies over six stimulation sites (bilateral primary motor cortex, and bilateral dorsolateral prefrontal cortex).

Study Details

Patients evaluated at Penn Presbyterian Medical Center for traumatic brain injury (TBI), who sign the informed consent, will undergo assessment of electrophysiologic potentials evoked by transcranial magnetic stimulation (TMS), using the Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel).

Key Dates

Start date
Mar 1, 2026
Status verified
Oct 2025
Primary completion
Mar 31, 2030
Completion
Jul 31, 2030

Study Design

Enrollment
215 participants (estimated)

Arms

  • Arm: Traumatic Brain Injury (Acute, Subacute, Chronic)
  • Arm: Healthy Control

Primary Outcome Measure

1. Differentiate between healthy controls and TBI participants in measured outputs of the DELPHI-MD device (WFA, STP, EPD, LPD, and Connectivity) [ Time Frame: Day 1 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of PennsylvaniaPhiladelphiaPennsylvania19104
TBIRI Research
[email protected]
267-271-4951
Ramon Diaz-Arrastia, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Philadelphia, PA

By research site
University of Pennsylvania· Philadelphia, PA

Related Studies